Glenmark launches RYALTRIS nasal spray in Brazil
In short
Glenmark has launched RYALTRIS nasal spray in Brazil for allergic rhinitis. The report says it is for people aged 12 and older with moderate to severe symptoms.
This matters because it gives Glenmark another product in a new market. The reporting does not say when the launch happened or how much it could add to sales.
What the reporting says
Glenmark launched the allergic rhinitis nasal spray RYALTRIS in Brazil, according to publisher-supplied reporting. The product is indicated for treating moderate to severe symptoms in people aged 12 years and older. The reporting does not state the launch date, sales outlook, or any expected revenue impact for Glenmark.
Why it matters
Glenmark launched the RYALTRIS nasal spray in Brazil, according to publisher-supplied company reporting. The product is indicated for treating moderate to severe allergic rhinitis symptoms in people aged 12 years and older. The reporting does not provide the launch date, commercial terms, or any forecast for sales or market share.